Stereotaxis STXS
NYSE STXS
$1.42 -0.02 (-1.39%)
At close: Aug 21, 2026 · 4:00 PM EDT

Stereotaxis (STXS) Notes Payables (2020 - 2021)

Stereotaxis (STXS) posted quarterly Notes Payables of $1.9 million for Q1 2021, up 61.57% quarter-over-quarter from $1.2 million in Q4 2020.

Stereotaxis (STXS) Notes Payables (2020 - 2021) Analysis & Trends

Stereotaxis (STXS) has reported Notes Payables for 2 consecutive years, with $1.9 million the latest figure, recorded in Q1 2021.

  • In Q1 2021, Notes Payables changed N/A year-over-year to $1.9 million; the TTM figure through Mar 2021 stood at $1.9 million (changed N/A YoY), while the FY2020 annual figure was $1.2 million, changed N/A from the prior year.
  • Notes Payables climbed to $1.9 million in Q1 2021 per STXS's latest filing, from $1.2 million in the prior quarter.
  • Across five years, Notes Payables topped out at $2.2 million in Q2 2020 and bottomed at $457244.0 in Q3 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn
10 Stereotaxis 141.91 Mn 127.29 Mn 3.79 Mn

Historic Data

Download Data
DateValue
Mar 31, 2021 1.91 Mn
Dec 31, 2020 1.19 Mn
Sep 30, 2020 457,244.00
Jun 30, 2020 2.16 Mn